| Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018 | 139 | 2018 |
| Operational definition of Active and Healthy Ageing (AHA): A conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19 (9), 955-960, 2015 | 77 | 2015 |
| Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2 (1), 1-8, 2013 | 68 | 2013 |
| Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018 | 59 | 2018 |
| Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS Genet 9 (2), e1003292, 2013 | 56 | 2013 |
| Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14 (4), 501-513, 2017 | 52 | 2017 |
| Health research with big data: Time for systemic oversight E Vayena, A Blasimme The journal of law, medicine & ethics 46 (1), 119-129, 2018 | 47 | 2018 |
| Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017 | 43 | 2017 |
| Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Maņas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015 | 37 | 2015 |
| Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016 | 35 | 2016 |
| Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ... Neuroscience & Biobehavioral Reviews 42, 170-179, 2014 | 35 | 2014 |
| Regulation of cell-based therapies in Europe: current challenges and emerging issues A Blasimme, E Rial-Sebbag Stem cells and development 22 (S1), 14-19, 2013 | 33 | 2013 |
| Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018 | 30 | 2018 |
| Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018 | 25 | 2018 |
| Improving the measurement of scientific success by reporting a self-citation index JW Flatt, A Blasimme, E Vayena Publications 5 (3), 20, 2017 | 23 | 2017 |
| Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20–21, 2014 J Bousquet, D Kuh, M Bewick, T Strandberg, J Farrell, R Pengelly, ... European Geriatric Medicine 6 (2), 196-200, 2015 | 23 | 2015 |
| " Tailored-to-You": Public Engagement and the Political Legitimation of Precision Medicine A Blasimme, E Vayena Perspectives in Biology and Medicine 59 (2), 172-188, 2016 | 21 | 2016 |
| Big data and dementia: charting the route ahead for research, ethics, and policy M Ienca, E Vayena, A Blasimme Frontiers in medicine 5, 13, 2018 | 20 | 2018 |
| From evidence to action: promoting a multidimensional approach to mild cognitive impairment M Canevelli, A Blasimme, N Vanacore, G Bruno, M Cesari Journal of the American Medical Directors Association 16 (8), 710-711, 2015 | 17 | 2015 |
| Genomic incidental findings: reducing the burden to be fair V Anastasova, A Blasimme, S Julia, A Cambon-Thomsen The American Journal of Bioethics 13 (2), 52-54, 2013 | 16 | 2013 |
Effy VayenaETH ZurichVerified email at hest.ethz.ch
